NewsRoom Articles - Page 98 of 214

TuesdaySep 27, 2022 10:30 am

NFL Reveals That Players Wearing Guardian Caps Reduced Concussion Rates by More than 50%

A lot of football players often suffer concussions because their sports usually involve contact. Concussions are brain injuries caused by a blow to an individual’s head, which may or may not result in the loss of consciousness. These injuries sometimes cause temporary cognitive symptoms and have no specific cure. Concussion symptoms include confusion, headaches, loss of memory, lack of coordination, nausea and vomiting, ringing in the ears, dizziness, excessive fatigue and sleepiness. Data from a 2017 study found that 99% of tested NFL players, 91% of college football players and 88% of CFL players suffered from various stages of chronic…

MondaySep 26, 2022 10:30 am

UBC Scientists Believe Insulin Tablet to Treat Diabetes May Soon Be Available

A team of scientists at the University of British Columbia has revealed that it is close to developing an insulin pill. Insulin is a hormone the pancreas produces. This hormone is used to control the amount of sugar or glucose in the blood. Insulin deficiency can cause increased blood sugar as well as severe health issues such as heart disease, blindness, nerve damage, kidney problems, amputation and erectile dysfunction. Currently, the only way to administer insulin is through injections with syringes, pens or pumps. A few years ago, however, MIT researchers developed a capsule that could inject up to 300…

MondaySep 26, 2022 9:45 am

Odyssey Health, Inc. (ODYY) Reports Added Evidence of Proposed Concussion Therapy’s Safety at High Doses

Medical product developer Odyssey Health Inc. is dedicated to creating solutions for a variety of life-quality situations, such as early detection of heart disease, saving choking victims and treating nervous system ailments Odyssey Health’s primary focus has been advancing its combined device and drug solution for brain concussion injuries through the clinical test process to commercial fulfillment The therapeutic solution, currently known as PRV-002, is designed to deliver a synthetic neurosteroid to injured brain tissue, where it can reduce swelling and sustain needed blood flow The company’s human testing has demonstrated safety with “no serious adverse events,” and Odyssey is…

FridaySep 23, 2022 10:30 am

Study Finds That Endometriosis Prognosis Worsens as CNS Metastasis Occurs

Endometriosis is a disorder that causes the tissue that lines the inside of the uterus to grow outside the reproductive organ. It is associated with menstrual irregularities and pain and is estimated to affect around 10% of American women of reproductive age. The condition develops into endometrial cancer when the endometrial cells grow out of control, leading to the development of a tumor. Unfortunately, there is no cure for endometriosis, and current treatments can only do so much to ease the condition’s symptoms so they don’t interfere with an individual’s day-to-day activities. Prior studies have found that patients with endometrial…

ThursdaySep 22, 2022 12:38 pm

New Research Finds Thinning Retina May Signal Onset of Alzheimer’s

Alzheimer’s is a progressive neurological disease that causes brain cells to shrink and die. It is characterized by memory problems, visual-spatial issues and impaired judgment. The Centers for Disease Control and Prevention (CDC) estimates that around 5.8 million Americans have Alzheimer’s disease and similar dementias. Although there is no cure for Alzheimer’s disease, early diagnosis of the neurological condition can allow for treatment and a better quality of life. Researchers have long theorized that eyes, specifically the retina, can act as a window into the brain and allow physicians to diagnose Alzheimer’s during the early stages. Backed by a growing…

WednesdaySep 21, 2022 2:16 pm

Study Finds Using Social Media May Negatively Affect Youths’ Mental Health

In 2004, Mark Zuckerberg launched Facebook, and within days, some 600 students had created their accounts on the social platform. Today, the number of users on the platform stands at 2.93 billion. Researchers theorize that the expansion of this social platform may have affected the mental well-being of youth. This is backed by CDC data, showing that between 2000 and 2007, the suicide rate among individuals aged between 10 and 24 was stable. However, in the period between 2007 and 2017, the rate increased by 57%. Given this trend, it is important to understand the relationship between the use of…

TuesdaySep 20, 2022 12:00 pm

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Clinical Trial Marks ‘Tremendous’ Milestone as First Participants Receive Initial CYB003 Dose

First dose is administered as first-ever novel psilocybin analog enters clinical development Cybin believes CYB003 has potential to successfully address the challenges and limitations of oral psilocybin The high level of participant interest in the study indicates a significant unmet need for alternative treatment options for major depressive disorder (“MDD”) Cybin (NEO: CYBN) (NYSE American: CYBN) has reached a milestone in its mission to create safe and effective therapeutics. The company is conducting a phase 1/2a trial evaluating CYB003, its lead investigational molecule and the first-ever novel psilocybin analog to enter clinical development. Late last month, the first two trial participants…

TuesdaySep 20, 2022 11:15 am

QSAM Biosciences Inc. (QSAM) Working to Halt, Regress Bone Tumors in Children Through Therapeutic Radiopharmaceuticals

Overall incidence of childhood cancer is on the increase, averaging 0.8% increase per year since 1975, reports leading advocacy organization QSAM developing therapeutic radiopharmaceuticals as safer, more efficacious alternatives to address unmet medical needs, underserved patient populations Company creating pipeline of novel radiotherapeutics to serve multiple indications with its lead product, CycloSam With the overall incidence of childhood cancer on the rise, the work of QSAM Biosciences (OTCQB: QSAM) is becoming increasingly important. QSAM Biosciences is a clinical-stage biotechnology company focused on developing and bringing to market targeted therapeutic radiopharmaceuticals and advancing the fight against cancer, including the underserved pediatric…

TuesdaySep 20, 2022 11:07 am

Scientists Discover Unexpected Way in Which Air Pollution Causes Cancer

Scientists have for the longest time believed that cancer begins to develop when cells in the body acquire more mutations and multiply at an abnormal rate. However, new research has shed light on how air pollution can cause cancer, a discovery that could completely change the understanding of how tumors develop. This study, which was conducted by scientists at the Francis Crick Institute in London, found that air pollution was awakening old damaged cells in the body instead of damaging healthy cells. The investigators, who are also based at University College London, were focused on finding what could trigger the…

TuesdaySep 20, 2022 9:00 am

HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’

HeartBeam is a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere In September 2022, the company announced it was granted a patent for its 12-lead ECG Patch Monitor, opening a pathway to ischemia and arrhythmia detection innovation in ECG Patch products In August 2022, the company announced it was seeking FDA approval for its HeartBeam AIMI platform technology used to detect and diagnose heart attacks On November 15, 2021, HeartBeam had its IPO on the Nasdaq under ticker symbol ‘BEAT’ The company’s management team has significant experience in software…